Search published articles


Showing 3 results for Biotechnology

Najaf Allahyari Frad,
Volume 6, Issue 1 (4-2013)
Abstract

Biotechnology is a high technology that is bound to play an important role in the future world due to its wide range of applications in different parts of industry, agriculture, medicine, environment and so on. In our country special attention has been paid to biotechnology as a strategic technology. While the production and consumption of genetically modified organisms (GMO) products is witnessing an upsurge in the world on account of the value of cultivation and production, Iran does not have a noticeable share in this field. Food and agriculture organization (FAO) has predicted that food preparation for the 9.1 billion world population in 2050 will require a 70 percent increase in food production throughout the world and a 100 percent increase in food production in developing countries. Report of the International Service for the Acquisition of Agri-biotech Applications (ISAAA) indicates that biotechnology can be a key solution to the growing demand for food in the world. The development and operation of targeted biotechnology in compliance with all aspects of biosafety and bioethics will cause food production and productivity to increase. Naturally, this depends on culture making, production and commercialization of GMO products and changing the society’s consumption pattern. Jurisprudential views of consumption of GMO products, however, will lead us to bioethics-related issues and proper use of such products. In this study the views of grand jurisprudents were pursued about various aspects of direct and indirect consumption of GMO products in the form of four questions. All of the grand jurisprudents permit consumption of GMO products, and some do so with reservations: that they do not entail losses in the present and future, and that product information be truthfully disclosed to customers. This paper reports the responses received, and discusses the bioethical aspects of the views of grand ayatollahs.
Abdolhassan Kazemi, Soraya Mahmoud,
Volume 7, Issue 5 (1-2015)
Abstract

Genes are considered as “green gold” in this era of biotechnology. Currently, multinational companies and governments search continents to find this valuable asset in the hope to discover people with unique genetic characteristics that can be converted into capital and marketed in the future. Modern economy provides the framework to analyze any new technology from the advantage perspective and has vastly transformed the concept of capital and market thus, humans or any organism with specific genetic characteristics can be converted to capital and offered in profitable markets. Patenting and ownership of genetic resources without consideration for principles of inherent human rights will impact the society and result in a violation of these rights, especially those of vulnerable individuals and groups. In spite of the numerous benefits of biotechnology for individuals and the society, the risks to human dignity, equality, health, autonomy and research, as well as the possibility of information abuse should not be ignored, especially considering the alliance between technology and economy. Biotechnology can make claims to ownership of human life and desired genetic traits, and this is a problem caused by the biotechnology revolution in developing countries and consequently, indigenous peoples of these countries have shown different reactions to such issues. This article will discuss “human commodification”, which is a serious concern in the field of biotechnology in our world today
Fatemeh Bahmani, Mahshad Noroozi, Narjes Kolahchi, Mostafa Ghanei,
Volume 16, Issue 1 (3-2023)
Abstract

Emerging biotechnologies contribute significantly to societal well-being by influencing social, economic, and health fields. Attitudes toward biotechnologies differ, in various situations and over time, based on new understanding and evidence. One issue always emphasized in the ethical evaluation of emerging technologies is their dangerous and problematic aspects for human life and well-being. Simultaneously, ethical assumptions can influence ethical decision-making toward employing these technologies, including liberty, technological optimism, determinism, the lifecycle, power, the form of life, technology neutrality, ambiguity, uncertainty, dual-use transformative potential, and the challenges that will be raised by them. For the ethical assessment of emerging technology, six principal methodologies are employed. The "principles-based approach" focuses on obtaining the intended goals rather than determining specific requirements, laws, standards, and obligations and avoids checklist design. The ethical principles raised by the principles-based approach are presented in this article, including risk-cost-benefit, adherence to individual rights, sustainability, naturalness, precautionary, trajectory, responsible stewardship, public beneficence, justice and fairness, democratic deliberation, and intellectual freedom.Finally, by presenting a conceptual model in applying the principles above in forming biotechnologies, eighteen operational recommendations are presented to facilitate the ethical evaluation and monitoring of emerging biotechnologies in the policy-making process in Iran.


Page 1 from 1     

© 2026 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by: Yektaweb